Skip to main content
. 2020 Sep 8;77(11):1–11. doi: 10.1001/jamaneurol.2020.3075

Table 2. Demographic and Clinical Characteristics of the Patients According to Treatment Groups Based on Initial Systolic Blood Pressure (SBP) Strata.

Characteristic Patients, No. (%)
SBP ≥220 mm Hg SBP <220 mm Hg
Intensive treatment (n = 110) Standard treatment (n = 118) Intensive treatment (n = 390) Standard treatment (n = 381)
Age, mean (SD), y 59.9 (13.5) 58.1 (12.9) 62.6 (12.9) 63.1 (12.9)
Male 66 (60.0) 71 (60.2) 238 (61.0) 244 (64.0)
Race
American Indian or Alaska Native 0 0 1 (0.3) 3 (0.8)
Asian 54 (49.1) 56 (47.5) 223 (57.2) 228 (59.8)
Black 21 (19.1) 22 (18.6) 52 (13.3) 36 (9.4)
White 35 (31.8) 38 (32.2) 107 (27.4) 107 (28.1)
Other or unknown 0 2 (1.7) 7 (1.8) 7 (1.8)
Ethnicity
Hispanic 10 (9.1) 15 (12.7) 28 (7.2) 26 (6.8)
Not Hispanic 96 (87.3) 98 (83.1) 351 (90.0) 346 (90.8)
Unknown/not reported 4 (3.6) 5 (4.2) 11 (2.8) 9 (2.4)
Baseline Glasgow Coma Scale score
Mean (SD) 13.4 (2.3) 13.6 (2.2) 13.8 (2.0) 13.7 (2.1)
Median (range) 14 (3-15) 15 (6-15) 15 (3-15) 15 (3-15)
Baseline National Institutes of Health Stroke Scale score
Mean (SD) 12.6 (6.9) 11.6 (6.8) 11.5 (6.5) 11.6 (7.3)
Median (range) 12 (1-30) 10 (0-39) 11 (0-40) 11 (0-40)
Initial SBP, mean (SD), mm Hg 236.5 (16.3) 237.3 (15.8) 189.7 (19.5) 190.0 (18.4)
SBP prerandomization, mean (SD), mm Hg 180.2 (30.4) 178.9 (28.3) 174.1 (24.0) 173.0 (22.8)
Lowest SBP after randomization, mean (SD), mm Hg
2-3 h 121.7 (15.2) 140.4 (19.2) 120.2 (13.6) 138.3 (16.0)
6-7 h 122.1 (12.2) 141.7 (17.3) 118.6 (12.8) 139.4 (16.5)
23-24 h 127.1 (13.4) 152.6 (14.8) 126.5 (12.2) 145.4 (16.2)
Intracerebral hematoma volume, mean (SD) 13.7 (12.5) 13.3 (11.2) 13.4 (11.8) 14.2 (12.8)
Location of hemorrhage
Thalamus 38 (34.5) 40 (33.9) 130 (33.3) 111 (29.1)
Basal ganglia 66 (60.0) 67 (56.8) 216 (55.4) 213 (55.9)
Cerebral lobe 6 (5.5) 11 (9.3) 44 (11.3) 55 (14.4)